Cardiovascular Alterations associated with Interleukin-2 Therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (69)
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
1987 • 10,774 citations
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
1987 • 2,769 citations
Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
1993 • 1,811 citations
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
1992 • 1,635 citations
Macrophage Cytotoxicity: Role for L-Arginine Deiminase and Imino Nitrogen Oxidation to Nitrite
1987 • 1,533 citations
Profound but Reversible Myocardial Depression in Patients with Septic Shock
1984 • 1,518 citations
Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
1987 • 1,224 citations
The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
1987 • 1,171 citations
The Cardiovascular Response of Normal Humans to the Administration of Endotoxin
1989 • 1,096 citations
Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
1989 • 1,003 citations
Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
1991 • 873 citations
A new technique for measurement of cardiac output by thermodilution in man
1971 • 752 citations
Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer
1993 • 639 citations
Nitrogen Oxide Levels in Patients After Trauma and During Sepsis
1991 • 609 citations
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis
1990 • 562 citations
Nitric Oxide And Carbon Monoxide Produce Activity-Dependent Long-Term Synaptic Enhancement in Hippocampus
1993 • 562 citations
Mammalian Nitric Oxide Synthases
1992 • 514 citations
EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.
1990 • 512 citations
Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.
1992 • 494 citations
Role of nitric oxide in gastrointestinal and hepatic function and disease
1992 • 493 citations
Endothelial Cell Production of Nitrogen Oxides in Response to Interferon in Combination With Tumor Necrosis Factor, Interleukin-1, or Endotoxin
1990 • 474 citations
Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway
1990 • 462 citations
High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer
1986 • 459 citations
Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
1991 • 409 citations
Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
1991 • 403 citations
Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages
1991 • 391 citations
Role of nitric oxide in maintaining vascular integrity in endotoxin‐induced acute intestinal damage in the rat
1990 • 369 citations
The Effect of Fluid Loading, Blood Transfusion, and Catecholamine Infusion on Oxygen Delivery and Consumption in Patients with Sepsis1,2
1986 • 367 citations
Modulation of Nitrogen Oxide Synthesis In Vivo: NG-Monomethyl-L-Arginine Inhibits Endotoxin-Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage
1990 • 345 citations
Nitric Oxide Potently and Reversibly Deenergizes Mitochondria at Low Oxygen Tension
1994 • 324 citations
Macrophage and endothelial cell nitric oxide synthesis: Cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine
1990 • 277 citations
Shock and Multiple-Organ Dysfunction after Self-Administration of Salmonella Endotoxin
1993 • 265 citations
Cardiorespiratory effects of immunotherapy with interleukin-2.
1989 • 246 citations
Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine.
1990 • 230 citations
Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis.
1987 • 219 citations
Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients
1988 • 210 citations
Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
1988 • 197 citations
Studies of interferon as a regulator of hematopoietic cell proliferation.
1985 • 195 citations
The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2
1988 • 181 citations
Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients
1987 • 166 citations
Effects of NG-Methyl-L-arginine, NG-Nitro-L-arginine, and Aminoguanidine on Constitutive and Inducible Nitric Oxide Synthase in Rat Aorta
1994 • 143 citations
Circulating Factors in the Etiology of Pulmonary Insufficiency and Right Heart Failure Accompanying Severe Sepsis (Peritonitis)
1970 • 120 citations
Effect of Endogenous Nitric Oxide on Mitochondrial Respiration of Rat Hepatocytes In Vitro and In Vivo
1991 • 114 citations
Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects [see comments]
1990 • 109 citations
Cardiovascular performance with E. coli challenges in a canine model of human sepsis
1988 • 83 citations
Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans.
1988 • 80 citations
Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
1989 • 79 citations
Nitric oxide hemoglobin in mice and rats in endotoxic shock
1991 • 76 citations
Inhibition of Interleukin-1- -Induced Nitric Oxide Synthase in Vascular Smooth Muscle and Full Reversal of Interleukin-1- -Induced Hypotension by N -Amino-L-arginine
1992 • 76 citations
Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment.
1990 • 75 citations
High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell Carcinoma
1990 • 71 citations
Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors
1991 • 65 citations
Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia
1992 • 60 citations
Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C
1992 • 60 citations
Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses.
1993 • 52 citations
Fibrinolysis in Critically III Patients
1989 • 52 citations
Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy.
1992 • 42 citations
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs
1994 • 41 citations
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs
1994 • 40 citations
Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
1992 • 29 citations
Central Nervous System Toxicity of Biological Response Modifiers
1990 • 19 citations
Lessons from the clinical trials of interleukin-2.
1990 • 15 citations
A comparison of the cardiopulmonary effects of continuous versus bolus infusion of recombinant interleukin-2 in sheep.
1988 • 14 citations
Blood coagulation abnormalities during adoptive immunotherapy with interleukin-2 (r-Met Hu IL-2 [ala 125])
1991 • 11 citations
Inotropic and vasoactive drug treatment of interleukin 2 induced hypotension in sheep.
1989 • 10 citations
Treatment with pentoxifylline and ciprofloxacin reduces the toxicity of high-dose interleukin-2 and lymphokine-activated killer cells.
1993 • 10 citations
Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation
1993 • 5 citations
Book Review Courage under Siege: Starvation, Disease, and Death in the Warsaw Ghetto By Charles G. Roland. 352 pp., illustrated. New York, Oxford University Press, 1992. $25. 0-19-506285-X
1993 • 1 citations
Deleted Work
1955 • 0 citations